Suven Pharma Q3 net rises 78% to ₹83.29 cr.
Global private equity major Advent International firm Suven Pharmaceuticals reported consolidated net profit in December quarter rose more than 78% to ₹83.29 crore from ₹46.75 crore a year earlier. Sequentially,…